Cointime

Download App
iOS & Android

CRISPR Therapeutics

company
Funding Round
Series B
Money Raised
$ 29M
Propotion
-
Post Valuation
-

Current Round Investors

Investor Name Invest Money Lead Investor Propotion
Bayer Global Investments - Yes - Detail
Versant Ventures - - - Detail

Historical Financing

Announced Date Round Money Raised Investors
Apr 29, 2015 Series A $ 35M Versant Ventures Detail
Apr 24, 2014 Series A $ 25M Versant Ventures Detail